BioSig Technologies - 股票

BioSig Technologies 负债 2024

BioSig Technologies 负债

-0.19 USD

股票代码

BSGM

ISIN

US09073N2018

WKN

A2N5TW

在2024年,BioSig Technologies的债务为-0.19 USD,与前一年-0.36 USD的总债务相比变动了-46.78%

BioSig Technologies Aktienanalyse

BioSig Technologies在做什么?

Biosig Technologies Inc is a medical technology company based in New York, specializing in the development of advanced electrophysiological (EP) instruments and accessories for use in hospitals and clinics. The company was founded in 2009 and successfully went public in June 2018. The main task of Biosig Technologies is to provide doctors and medical professionals with helpful instruments that simplify the difficult work of EP tests and ablations. The development of EP instruments typically requires high specialization, as knowledge of both electrophysiology and engineering is required. However, Biosig has already gained a high level of expertise in this field and has established itself as a leading company in the industry. Biosig Technologies' business model is based on selling EP instruments and accessories to hospitals and clinics in the US and international markets. The products include the "PURE EP System," an electrophysiological signal processing and recording system specifically designed for use in EP tests and ablations. The "PURE EP System" allows doctors to obtain accurate information about the electrical activity of the heart in order to improve the diagnosis and treatment of cardiac arrhythmias. The "PURE EP System" has proven its excellence in practice and is successfully used by many clinics and hospitals in the US. The system offers higher sensitivity and accuracy than conventional electrophysiological instruments, enabling better differentiation and representation of signals originating from different heart tissues. This allows doctors to make more accurate diagnoses and develop more targeted treatment strategies. Biosig Technologies offers a wide range of products and services tailored to the needs of customers in various areas of healthcare. The company also provides excellent customer support and training to ensure that users properly utilize the instruments and maximize their benefits. In addition to the EP field, the company is also exploring the use of the technology in other areas of medicine. Biosig Technologies actively works on the development of instruments to improve respiratory monitoring and facilitate the use of robots in surgery. The company plans to bring more instruments and accessories to the market in the future to expand its portfolio and meet additional customer needs. Biosig Technologies is a dynamic company with a high degree of innovation and a strong focus on the needs of doctors and medical professionals. The company aims to improve healthcare by providing advanced instruments and accessories, making a positive contribution to society. BioSig Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

负债的详细信息

BioSig Technologies的债务结构理解

BioSig Technologies的总债务是指该公司欠外部各方的累积金融义务。这可能包括短期和长期贷款、债券、贷款和其他金融工具。评估公司的债务对于评估其财务状况,风险概况以及运营和扩展业务的能力至关重要。

年对年对比

通过对BioSig Technologies多年债务结构的分析,可以洞察公司的财务策略和稳定性。债务的减少可能暗示了财务实力和运营效率,而债务的增加可能表明投资增长或潜在的财务挑战。

对投资的影响

投资者会密切关注BioSig Technologies的债务,因为这会影响公司的风险和收益概况。过度的债务可能导致财务压力,而适度并且管理良好的债务可能是增长和扩张的催化剂。这使得债务成为投资评估的重要一环。

债务波动的解读

BioSig Technologies债务水平的变化可能归因为各种运营和策略因素。债务的增加可能旨在资助扩张项目或提高运营能力,而债务的减少可能意味着利润的实现或是一种减小财务风险和杠杆效应的方法。

关于BioSig Technologies股票的常见问题

BioSig Technologies今年的债务有多高?

BioSig Technologies今年的债务水平为-0.19 USD。

BioSig Technologies的债务与去年相比有多高?

BioSig Technologies的债务与去年相比增长了-46.78% 下降了

BioSig Technologies的投资者高额债务会有什么后果?

对于BioSig Technologies的投资者来说,高额债务可能构成风险,因为它会使公司的财务状况变得较弱,可能会影响其履行义务的能力。

BioSig Technologies的投资者低债务会有什么后果?

低债务意味着BioSig Technologies拥有强大的财务地位,并且能够履行其义务,而不会导致其财务负担过重。

BioSig Technologies的债务增加对公司会有什么影响?

BioSig Technologies的债务增加可能会影响公司的财务状况,从而导致其财务负担增加。

BioSig Technologies的债务减少会对公司产生什么影响?

将BioSig Technologies的债务降低可以增强公司的财务状况并提高其履行财务义务的能力。

BioSig Technologies的债务受哪些因素影响?

影响BioSig Technologies负债的一些因素可能包括投资、收购、运营成本和营业收入的发展。

为什么BioSig Technologies的债务对投资者如此重要?

BioSig Technologies的债务对投资者来说很重要,因为它是公司财务稳定性的指标,并且能向投资者提供有关公司如何履行其财务义务的信息。

BioSig Technologies可以采取哪些战略措施来改变债务状况?

为了改变债务状况,BioSig Technologies可以采取包括削减成本、增加收入、出售资产、接受投资或合作伙伴关系等措施。公司必须对其财务状况进行彻底审查,以确定最佳的战略措施来改变其债务状况。

BioSig Technologies支付多少股息?

在过去的12个月中,BioSig Technologies支付了 的股息。这相当于大约的股息收益率。在未来的12个月内,BioSig Technologies预计将支付0 USD的股息。

BioSig Technologies的股息收益率有多高?

BioSig Technologies当前的股息收益率为。

BioSig Technologies什么时候支付股息?

BioSig Technologies按季度支付股息。这些股息将在月份分发。

BioSig Technologies的股息有多安全?

BioSig Technologies 在过去0年里每年都支付了股息。

BioSig Technologies的股息有多高?

预计未来12个月的股息将达到0 USD。这相当于0 %的股息收益率。

BioSig Technologies位于哪个行业?

BioSig Technologies 被分配到“健康”板块。

Wann musste ich die Aktien von BioSig Technologies kaufen, um die vorherige Dividende zu erhalten?

要获得BioSig Technologies在支付的0 USD的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

BioSig Technologies最后一次支付股息是什么时候?

上一次股息发放日期为。

BioSig Technologies在2023年的股息是多少?

在2023年,BioSig Technologies 分配了0 USD作为股息。

BioSig Technologies 的股息是以哪种货币支付的?

BioSig Technologies的股息将以USD的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

Andere Kennzahlen von BioSig Technologies

我们对BioSig Technologies 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和BioSig Technologies 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: